Investor Relations

Conversion Labs is a rapidly growing direct to consumer telemedicine and wellness company. In addition to our proven online marketing expertise, we have built a technology platform, online pharmacy infrastructure and nationwide physician network to treat patients, prescribe prescription medications, and ship prescription and over the counter medications directly to patients in all 50 states. We believe telemedicine will transform the American healthcare system by increasing access to care and improving outcomes. We’re proud to be a leader in this rapidly evolving space.

Investor Documents

Investor Presentation

See our latest corporate presentation.

'20 Letter to Shareholders

See our latest shareholder letter.

2019 Annual Filing

See our latest annual filing.


Latest News

{{ news.pubDate }}

{{ `${news.title}` }}

Read More

Receive automated Investor Alerts directly to your inbox

Stock Information

SEC Filings

{{ `${sec.title}` }}

{{ sec.description }}

Investor Contact Information


Juan Manuel Piñeiro Dagnery
T: (866) 351-5907

Investor Relations

Ron Both, CMA
Email Contact
T: 949-432-7566

Transfer Agent

Worldwide Stock Transfer, LLC
One University Plaza, Suite 505
Hackensack, NJ 07601